Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Myriad Genetics Inc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 194
- +9 vs. Q3 2023
- Shares held
- 89.9M
- +7.20M (+8.7%) vs. Q3 2023
- Total value
- $1.72B
- +$394.3M (+29.7%) vs. Q3 2023
- New holders
- 28
- 78 more added
- Sold out
- 19
- 61 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MYGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 196 | $507.8M |
| Q1 2026 | 204 | $519.2M |
| Q4 2025 | 221 | $567.1M |
| Q3 2025 | 221 | $639.8M |
| Q2 2025 | 221 | $480.5M |
| Q1 2025 | 228 | $832.9M |
| Q4 2024 | 221 | $1.27B |
| Q3 2024 | 246 | $2.48B |
| Q2 2024 | 223 | $2.25B |
| Q1 2024 | 186 | $2.00B |
| Q4 2023 | 194 | $1.72B |
| Q3 2023 | 186 | $1.33B |
| Q2 2023 | 188 | $1.88B |
| Q1 2023 | 190 | $1.91B |
| Q4 2022 | 196 | $1.17B |
| Q3 2022 | 191 | $1.55B |
| Q2 2022 | 199 | $1.46B |
| Q1 2022 | 205 | $1.99B |
| Q4 2021 | 197 | $2.16B |
| Q3 2021 | 213 | $2.56B |
| Q2 2021 | 201 | $2.31B |
| Q1 2021 | 197 | $2.25B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Myriad Genetics Inc; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −17,960−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −11,866−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −11,779−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −11,660−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −10,709−100.0% | Sold out |
| Traverso Chambers Private Wealth Management, LLC | 0 | $0 | 0.00% | −10,357−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −5,200−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −4,055−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −2,636−100.0% | Sold out |
| Park Place Capital Corp | 0 | $0 | 0.00% | −1,366−100.0% | Sold out |
| Huntington National Bank | 0 | $0 | 0.00% | −199−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −182−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Steward Financial Group LLC | – | – | – | – | Not filed |